Ion Beam Applications's EBIT per Share for the
six
months ended in Dec. 2025 was $0.57.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.87.
During the past 12 months, the average EBIT per Share Growth Rate of Ion Beam Applications was 118.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 64.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -10.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Ion Beam Applications's EBIT per Share or its related term are showing as below:
IOBCF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -60.9 Med: -6 Max: 81.1
Current: 64.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Ion Beam Applications was 81.10% per year. The lowest was -60.90% per year. And the median was -6.00% per year.
IOBCF's 3-Year EBIT Growth Rate is ranked better than 93.48% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.65
vs IOBCF: 64.70
Ion Beam Applications (OTCPK:IOBCF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Ion Beam Applications EBIT per Share Related Terms
Ion Beam Applications EBIT per Share Historical Data
* Premium members only.
The historical data trend for Ion Beam Applications's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.87
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ion Beam Applications (IOBCF) has a EBIT per Share of $0.87 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Ion Beam Applications and its competitors. According to the industry distribution chart, Ion Beam Applications ranks #45 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 6.5%.
Is Ion Beam Applications' EBIT per Share too high?
Ion Beam Applications' current EBIT per Share is $0.87. The Medical Devices & Instruments industry median EBIT per Share is 9.65. Ion Beam Applications' value of $0.87 is 91% below this industry median. Based on the distribution chart, Ion Beam Applications ranks #45 out of 690 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ion Beam Applications has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #45 out of 690 companies for EBIT per Share. This places Ion Beam Applications in the top 7% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 9.65. Ion Beam Applications' value of $0.87 is 91% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.65, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current EBIT per Share of $0.87 is 91% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current EBIT per Share is $0.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.71, compared to a current price of $19.00 — trading 1.5% above its estimated fair value. The current EBIT per Share is $0.87 and 91% below the Medical Devices & Instruments industry median of 9.65. Ion Beam Applications' overall GF Score™ is 83/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current EBIT per Share is $0.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (IOBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be overvalued.
The current stock price of $19.00 is trading 1.5% above its estimated GF Value™ of $18.71.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for IOBCF:
EBIT per Share: $0.87
GF Value™: $18.71 vs. price of $19.00 (1.5% above fair value)
Industry Position: 91% below the Medical Devices & Instruments median (#45 of 690)
No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
83GF Score
Get the complete analysis for IOBCF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOBCF has been successfully added to your 
